RBL2 and cancer: The interaction between rbr-2 and daf-2 in C. elegans may be conserved in mammals, as IGF-1 receptor and RBP-2 demethylase activities were shown to mediate the emergence and maintenance of a ‘drug-tolerant’ state of cancer cell lines (Sharma et al., 2010).